Brighton Jones LLC’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,159
Closed -$12K 693
2024
Q3
$12K Sell
1,159
-127
-10% -$2.11K ﹤0.01% 577
2024
Q2
$25.3K Hold
1,286
﹤0.01% 624
2024
Q1
$32.9K Buy
1,286
+83
+7% +$2.13K ﹤0.01% 619
2023
Q4
$33.2K Sell
1,203
-8
-0.7% -$488 ﹤0.01% 568
2023
Q3
$73.6K Sell
1,211
-25
-2% -$1.76K ﹤0.01% 527
2023
Q2
$81.3K Sell
1,236
-142
-10% -$10.4K ﹤0.01% 528
2023
Q1
$87.6K Hold
1,378
0.01% 504
2022
Q4
$191K Hold
1,378
0.01% 444
2022
Q3
$174K Buy
1,378
+25
+2% +$2.83K 0.01% 431
2022
Q2
$112K Sell
1,353
-7
-0.5% -$543 0.01% 448
2022
Q1
$132K Buy
1,360
+7
+0.5% +$924 0.01% 493
2021
Q4
$270K Sell
1,353
-776
-36% -$183K 0.01% 402
2021
Q3
$527K Sell
2,129
-5
-0.2% -$1.43K 0.03% 259
2021
Q2
$884K Buy
2,134
+95
+5% +$37.6K 0.05% 174
2021
Q1
$797K Buy
2,039
+21
+1% +$10.3K 0.05% 173
2020
Q4
$1.13M Sell
2,018
-3
-0.1% -$1.9K 0.07% 118
2020
Q3
$1.41M Buy
2,021
+117
+6% +$91.2K 0.1% 88
2020
Q2
$1.5M Buy
1,904
+3
+0.2% +$2.26K 0.12% 74
2020
Q1
$1.13M Sell
1,901
-2
-0.1% -$1.95K 0.12% 84
2019
Q4
$2.16M Hold
1,903
0.23% 57
2019
Q3
$2.26M Hold
1,903
0.26% 44
2019
Q2
$3.13M Buy
1,903
+24
+1% +$41.5K 0.37% 33
2019
Q1
$3.83M Buy
1,879
+1
+0.1% +$1.76K 0.46% 25
2018
Q4
$2.41M Buy
1,878
+3
+0.2% +$4.6K 0.35% 37
2018
Q3
$3.54M Sell
1,875
-107
-5% -$221K 0.44% 24
2018
Q2
$4.03M Buy
1,982
+1
+0.1% +$2.28K 0.52% 24
2018
Q1
$4.38M Sell
1,981
-735
-27% -$1.87M 0.6% 25
2017
Q4
$6.27M Buy
2,716
+106
+4% +$215K 0.76% 20
2017
Q3
$4.64M Hold
2,610
0.6% 24
2017
Q2
$3.55M Buy
+2,610
New +$3.15M 0.5% 24
2016
Q4
Sell
-3,271
Closed -$2.87M 118
2016
Q3
$2.87M Hold
3,271
0.46% 28
2016
Q2
$1.83M Hold
3,271
0.32% 38
2016
Q1
$1.8M Buy
3,271
+1,991
+156% +$1.22M 0.33% 37
2015
Q4
$1.06M Sell
1,280
-154
-11% -$154K 0.21% 57
2015
Q3
$1.59M Buy
1,434
+199
+16% +$363K 0.34% 36
2015
Q2
$2.69M Sell
1,235
-79
-6% -$161K 0.62% 23
2015
Q1
$2.06M Sell
1,314
-230
-15% -$303K 0.47% 25
2014
Q4
$1.83M Sell
1,544
-1,235
-44% -$825K 0.42% 32
2014
Q3
$1.29M Buy
+2,779
New +$1.28M 0.29% 42

Other funds holding BLUE

Brighton Jones LLC's BLUE Position: Q4 2024 in Review

Brighton Jones LLC sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 1,159 shares — an estimated $12K sold.

Brighton Jones LLC first reported a position in BLUE in Q3 2014 and held it in 39 quarters. The position peaked at $6.27M in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Brighton Jones LLC reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Brighton Jones LLC sold 1,159 bluebird bio shares in Q4 2024, an estimated $12K.
  • Brighton Jones LLC first reported a position in bluebird bio in Q3 2014 and held it in 39 quarters.
  • Brighton Jones LLC's bluebird bio position peaked at $6.27M in Q4 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Brighton Jones LLC's 13F filing for Q4 2024, filed 21 Jan 2025.